Document is current
Any future updates will be listed below
-
Authors
Théberge, Emilie T.
Selvage, Caroline
Thomas, Anita
LeMoine, Kaye M.
Robichaud, Rebecca
Zhou, Lily
Yeung, Darwin F.
West, Michael L.
Sirrs, Sandra
Lehman, Anna
,
-
Funding
Funding for this research was provided by:
Canadian Fabry Disease Initiative Research Consortium (Canadian Fabry Disease Initiative Research Consortium)
- License Information
-
More Information
Article History
Received: 16 March 2025
Accepted: 12 October 2025
First Online: 7 November 2025
Declarations
:
: This study used aggregate deidentified data of patients consented into the Canadian Fabry Disease Initiative registry, such that additional re-consent for publication was not required. Data analysis by E.T. was conducted under the approval of the University of British Columbia Clinical Research Ethics Board application #H17-00574.
: Not applicable.
: The authors have received funding for research (unrestricted), clinical trials, speaker fees, or advisory boards related to Fabry disease from Takeda, Amicus, Idorsia, Chiesi, or Sanofi Genzyme.
